HSPG2 and Ventricular arrhythmia: EA may upregulate hERG expression by inhibiting the Gq/PLC/PKCα pathway mediated by α1A-AR, shortening the MI-induced LQT interval, reducing the occurrence of ventricular arrhythmias, and ultimately playing a protective role in cardiac function (Figure 6).